• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELSOFT PLUS; GELSOFT PLUS BIFURCATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELSOFT PLUS; GELSOFT PLUS BIFURCATE Back to Search Results
Model Number GELSOFT PLUS BIFURCATE
Device Problem Stretched (1601)
Patient Problem Insufficient Information (4580)
Event Date 03/15/2022
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Trend analysis - no negative trend was identified.Communication/interviews - further information on event and its circumstances has been requested from the reporting site as well as clarification of the event/ device relationship.As yet no new information has been provided.Device not accessible for testing - the status of the device is currently unknown.Analysis if production records - qc, manufacturing and physical test records of the base material were retrieved and reviewed and show that the batch was manufactured to design specification and all tests met acceptance criteria.No device problem found - no issue has been found upon review of the retained device history records for this device/batch.Cause not established - limited information was provided and the graft has been discarded by the site, so no pbysical evaluation will be possible.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process and if an adverse trend develops action may be taken at that time.
 
Event Description
A gelsoft plus bifurcate was implanted on (b)(6) 2022.On (b)(6) 2022, the patient underwent a procedure relating to a wound infection.During the cta it was detected that the graft appeared close to the skin.During the intervention the graft was explanted as it appeared to be approx 3cm longer than was anticipated and was close to the skin.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELSOFT PLUS
Type of Device
GELSOFT PLUS BIFURCATE
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, renrewshire PA49R R
UK  PA49RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, renrewshire PA49R R
UK   PA49RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan
glasgow, renrewshire PA49R-R
UK   PA49RR
MDR Report Key14601344
MDR Text Key301990858
Report Number9612515-2022-00005
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881115511
UDI-Public05037881115511
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K955230
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 06/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/06/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2023
Device Model NumberGELSOFT PLUS BIFURCATE
Device Catalogue Number631407P-G
Device Lot Number21580230
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/17/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient SexFemale
-
-